19 June 2013
Keywords: tracleer, approved, eu, pah, fc, ii, actelion
Article | 11 August 2008
Actelion's Tracleer (bosentan) has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 August 2008
4 August 2008
7 July 2008
© 2013 thepharmaletter.com